We research genetic questions to help you make important decisions about your health.
MiraKind conducts cutting-edge research on a new class of genetic markers that provides powerful information about personalized disease risk, treatment, and management.
What We Do
MiraKind conducts patient-centric research to better understand novel inherited gene mutations, such as the KRAS-variant, to help:
Discover Answers
Discover clues in our DNA to identify individuals who are at higher risk of certain diseases, such as cancer.
Mitigate Risk
Apply answers to mitigate an individual’s disease risk through personalized prevention based on one's unique genetics.
Treat Disease
Recommend the most effective pathways for treatment, based on an individual’s unique response to therapy.
What We Believe
Knowledge Is Power
We have an endless list of questions, relentless determination to find the answers, and conviction in sharing our research findings.
We CAN Do Better
We CAN Do Better in the fight against cancer, and other devastating diseases, but it takes all of us to join the battle.
Together We Are Stronger
Which is why we provide a place where our members can share stories, learn from each other, and connect in a meaningful way. Visit the MiraKind community.
“It’s wonderful to feel that my participation in a study may have such meaning for others. I am so grateful my daughter, my daughter-in-law, and all young women will benefit from your efforts. For the first time since my diagnosis, I felt more powerful than my cancer.”
FROM THE DECEMBER 2014 ISSUE
The Little-Known Genetic Mutation Behind Many Aggressive Cancers
Despite the dangers of the KRAS-variant mutation, few doctors have heard of it. But one researcher is trying to change that.